Login / Signup

Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis plan.

Patrick MullerKashfia ChowdhuryCaroline GordonMichael R EhrensteinCaroline J Doré
Published in: Trials (2020)
ISRCTN: 47873003 . Registered on 28 November 2016. EudracT: 2015-005543-14 . Registered on 19 November 2018.
Keyphrases
  • systemic lupus erythematosus
  • disease activity
  • study protocol
  • phase iii
  • clinical trial
  • heart rate
  • phase ii
  • randomized controlled trial
  • stem cells
  • blood pressure
  • mesenchymal stem cells